C.R. BARD $105.14

down -0.01


24/5/2013 04:24 PM  |  NYSE : BCR  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 7% - BCR has underperformed the S&P 500 by 19%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by



People viewing BCR also viewed: , , , ,

Competitors

Ticker Name Volume % Change
RXPC RADIENT PHARMACEUTICALS 72.4K +1.00%
KADR ARCADIA RESOURCES 145.0K +0.63%
RGIN REGENICIN 34.5K +0.39%
AVVH AVVAA WORLD HEALTH CARE 13.0K +0.29%
NEPH NEPHROS 16.7K +0.20%

BCR Stock Analysis

  1. It Gets A Little Harder From Here For Covidien

    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  2. AngioDynamics Still Struggling To Get Back On Track

    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
Free Reports
  1. 5 Chart Patterns Every Investor Needs To Know

    Learn How to Use Technical Analysis to Your Advantage.
  2. Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  3. 21-page Book on Learning to Trade Options on Futures!

    Not too complex. Not too basic. Just enough information to help you ask the right questions so you can start using these markets.
Marketplace
Trading Center